We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Inhibition of Repressor Gene Spreads Antibiotic Resistance

By Biotechdaily staff writers
Posted on 21 Jan 2004
Researchers have identified a mechanism by which therapeutic agents can promote the spread of antibiotic resistance genes between different species of bacteria. More...


Investigators at Tufts University School of Medicine (Boston, MA, USA) focused their study on the collection of antibiotic-resistance genes called SXT that have been responsible for conferring resistance on four antibiotics (chloramphenicol, sulphamethoxazole, trimethoprim, and streptomycin) to nearly all strains of Vibrio cholerae in Asia.

They reported in the December 21, 2003, online edition of Nature that setR, one of the SXT genes that encode the SetR repressor protein, might be the key to the spread of antibiotic resistance. Normally SetR represses the setC and setD genes, which are activators of the excision and transfer of SXT. However, when the bacteria are placed under metabolic stress, their "SOS response” inhibits the activity of SetR, which increases the expression of genes necessary for SXT transfer and hence the frequency of transfer. One of the factors that can trigger the "SOS response” is treatment with antibiotics, including the frequently prescribed ciprofloxacin.

"This new understanding of the mechanism of transfer is very worrisome, for it shows how indiscriminant antibiotic use can promote the dissemination of antibiotic resistance,” explained senior author Dr. Matthew K. Waldor, associate professor of molecular biology and microbiology at Tufts University School of Medicine. "This is very different from the process by which antibiotic use selects for resistant organisms that are already in the population. We have shown how antibiotic use can promote the evolution of new antibiotic-resistant organisms that have obtained their resistance genes from other species.”



Related Links:
Tufts University School of Medicine

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.